Atlas Trials

Investigating the Effect of Ocrelizumab in African Americans and Caucasians With Relapsing Multiple Sclerosis

Clinical trial NCT04458688 · RECRUITING

Trial details

NCT number
NCT04458688
Sponsor
Wayne State University
Status
RECRUITING
Study type
OBSERVATIONAL
Multiple Sclerosis, Relapsing-Remitting
Start date
2021-11-20
Primary completion
2025-07-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.